Symrise AG

SY1

DE000SYM9999

Specialty Chemicals

Market Closed - Xetra Other stock markets 11:35:08 2024-04-26 am EDT			5-day change	1st Jan Change
99.86 ^EUR	-0.06%		-5.26%	+0.22%

Apr. 26	SYMRISE AG : Gets a Buy rating from Baader Bank	ZD
Apr. 26	SYMRISE AG : DZ Bank reiterates its Neutral rating	ZD

SYMRISE AG : JP Morgan keeps its Buy rating

March 22, 2024 at 03:45 pm EDT

In a research note published by Edward Hockin, JP Morgan advises its customers to buy the stock. The target price has been raised from EUR 115 to EUR 120.

Latest news about Symrise AG

SYMRISE AG : Gets a Buy rating from Baader Bank	Apr. 26	ZD
SYMRISE AG : DZ Bank reiterates its Neutral rating	Apr. 26	ZD
SYMRISE AG : Goldman Sachs reiterates its Sell rating	Apr. 26	ZD
SYMRISE AG : UBS reiterates its Buy rating	Apr. 26	ZD
SYMRISE AG : Baader Bank remains its Buy rating	Apr. 25	ZD
SYMRISE AG : UBS gives a Buy rating	Apr. 25	ZD
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	Apr. 25	DP
SYMRISE AG : Goldman Sachs keeps a Sell rating	Apr. 25	ZD
SYMRISE AG : Warburg Research reiterates its Neutral rating	Apr. 25	ZD
SYMRISE AG : Barclays gives a Neutral rating	Apr. 25	ZD
Symrise disappoints despite strong sales growth	Apr. 25	DP
SYMRISE AG : JP Morgan gives a Buy rating	Apr. 25	ZD
SYMRISE AG : Buy rating from Jefferies	Apr. 25	ZD
ROUDUP: Symrise grows strongly at the start of the year - investors nevertheless somewhat disappointed	Apr. 25	DP
Symrise prematurely weak - Jefferies: Bar high	Apr. 25	DP
Symrise posts quarterly sales above expectations	Apr. 25	RE
SYMRISE AG : Barclays reaffirms its Neutral rating	Apr. 22	ZD
SYMRISE AG : Gets a Neutral rating from Barclays	Apr. 08	ZD
SYMRISE AG : Gets a Neutral rating from Deutsche Bank	Apr. 05	ZD
SYMRISE AG : UBS reiterates its Buy rating	Apr. 03	ZD
Goldman raises target for Symrise to 101 euros - 'Sell'	Mar. 28	DP
SYMRISE AG : Gets a Sell rating from Goldman Sachs	Mar. 28	ZD
SYMRISE AG : DZ Bank reiterates its Neutral rating	Mar. 27	ZD
SYMRISE AG : Goldman Sachs keeps a Sell rating	Mar. 26	ZD
JPMorgan raises target for Symrise to 120 euros - 'Overweight'	Mar. 25	DP

Symrise AG is one of the world's leaders in developing, producing and marketing scents, flavors and functional ingredients. Net sales break down by family of products as follows: - nutritional ingredients (63%): for use in the manufacture of food products (beverages, candies, chocolates, cereals, dairy products, snacks, sauces, instant noodles, etc.) and in the manufacture of animal and fish feed; - perfumes and flavours (37%): perfumes, menthols, aromatic ingredients and chemicals for personal care products, oral care products, cleaning products, cosmetics, etc. Net sales are distributed geographically as follows: Germany (8.1%), Europe/Middle East/Africa (31.6%), the United States (24.4%), North America (2.1%), Asia/Pacific (20.7%) and Latin America (13.1%).

Sector

Specialty Chemicals

Calendar

2024-05-15 - Annual General Meeting

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Ratings for Symrise AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

99.86 EUR

Average target price

113.3 EUR

Spread / Average Target

+13.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
SYMRISE AG	+0.22%	14.9B
ECOLAB INC.	+11.47%	63.22B
SIKA AG	-3.47%	46.34B
GIVAUDAN SA	+13.72%	39.97B
FUJIFILM HOLDINGS CORPORATION	+17.83%	25.46B
EMS-CHEMIE HOLDING AG	+7.27%	18.68B
CELANESE CORPORATION	-0.57%	17.24B
POSCO FUTURE M CO., LTD.	-21.73%	15.81B
ALBEMARLE CORPORATION	-19.10%	13.74B
NITTO DENKO CORPORATION	+35.12%	12.81B

Other Specialty Chemicals

Symrise AG

Equities

SY1

DE000SYM9999

Specialty Chemicals

SYMRISE AG : JP Morgan keeps its Buy rating

Latest news about Symrise AG

Chart Symrise AG

Company Profile

Income Statement Evolution

Ratings for Symrise AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Specialty Chemicals